Your browser doesn't support javascript.
loading
Predicting response and survival in chemotherapy-treated triple-negative breast cancer.
Prat, A; Lluch, A; Albanell, J; Barry, W T; Fan, C; Chacón, J I; Parker, J S; Calvo, L; Plazaola, A; Arcusa, A; Seguí-Palmer, M A; Burgues, O; Ribelles, N; Rodriguez-Lescure, A; Guerrero, A; Ruiz-Borrego, M; Munarriz, B; López, J A; Adamo, B; Cheang, M C U; Li, Y; Hu, Z; Gulley, M L; Vidal, M J; Pitcher, B N; Liu, M C; Citron, M L; Ellis, M J; Mardis, E; Vickery, T; Hudis, C A; Winer, E P; Carey, L A; Caballero, R; Carrasco, E; Martín, M; Perou, C M; Alba, E.
Affiliation
  • Prat A; 1] Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035 Barcelona, Spain [2] Department of Medicine, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
  • Lluch A; Department of Medical Oncology and Department of Pathology, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
  • Albanell J; 1] Department of Medical Oncology, Hospital del Mar, IMIM, 08003 Barcelona, Spain [2] Department of Medical Oncology, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain.
  • Barry WT; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Fan C; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA.
  • Chacón JI; Department of Medical Oncology, Hospital Virgen de la Salud, 45004 Toledo, Spain.
  • Parker JS; 1] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA [2] Department of Genetics, University of North Carolina, Chapel Hill, NC 27519, USA.
  • Calvo L; Department of Medical Oncology, Complexo Hospitalario Universitario de A Coruña, 15002 A Coruña, Spain.
  • Plazaola A; Department of Medical Oncology, Onkologikoa, 20014 San Sebastián, Spain.
  • Arcusa A; Department of Medical Oncology, Consorci Sanitari de Terrassa, 08225 Barcelona, Spain.
  • Seguí-Palmer MA; Department of Medical Oncology, Corporació Sanitària Parc Taulí, 08208 Sabadell, Spain.
  • Burgues O; Department of Medical Oncology and Department of Pathology, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
  • Ribelles N; Department of Medical Oncology and Department of Pathology, Hospital Universitario Virgen de la Victoria, 29010 Malaga, Spain.
  • Rodriguez-Lescure A; Department of Medical Oncology, Hospital General de Elche, 03203 Alicante, Spain.
  • Guerrero A; Department of Medical Oncology, Instituto Valenciano de Oncología (IVO), 46009 Valencia, Spain.
  • Ruiz-Borrego M; Department of Medical Oncology, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
  • Munarriz B; Department of Medical Oncology, Hospital Universitario La Fe, 46026 Valencia, Spain.
  • López JA; Department of Medical Oncology, Hospital San Camilo, 28006 Madrid, Spain.
  • Adamo B; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035 Barcelona, Spain.
  • Cheang MC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA.
  • Li Y; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA.
  • Hu Z; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA.
  • Gulley ML; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA.
  • Vidal MJ; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035 Barcelona, Spain.
  • Pitcher BN; Alliance Statistical and Data Center, Duke University, Durham, NC 27708, USA.
  • Liu MC; Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Citron ML; ProHEALTH Care Associates, LLP, Lake Success, NY 11803, USA.
  • Ellis MJ; Department of Oncology, Washington University, St. Louis, MO 63130, USA.
  • Mardis E; Department of Oncology, Washington University, St. Louis, MO 63130, USA.
  • Vickery T; Department of Oncology, Washington University, St. Louis, MO 63130, USA.
  • Hudis CA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Winer EP; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
  • Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA.
  • Caballero R; GEICAM (Spanish Breast Cancer Research Group), 28700 Madrid, Spain.
  • Carrasco E; GEICAM (Spanish Breast Cancer Research Group), 28700 Madrid, Spain.
  • Martín M; 1] GEICAM (Spanish Breast Cancer Research Group), 28700 Madrid, Spain [2] Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, 28007 Madrid, Spain.
  • Perou CM; 1] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA [2] Department of Genetics, University of North Carolina, Chapel Hill, NC 27519, USA [3] Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27519, USA.
  • Alba E; Department of Medical Oncology and Department of Pathology, Hospital Universitario Virgen de la Victoria, 29010 Malaga, Spain.
Br J Cancer ; 111(8): 1532-41, 2014 Oct 14.
Article in En | MEDLINE | ID: mdl-25101563
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survival Analysis / Triple Negative Breast Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2014 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survival Analysis / Triple Negative Breast Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2014 Type: Article Affiliation country: Spain